JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
1.960
+0.100 (5.38%)
At close: Mar 27, 2026
HKG:2126 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 503.07 | 757.38 | 1,006 | 1,383 | 1,834 |
Short-Term Investments | - | 5.16 | 5.53 | 5.54 | 0.7 |
Cash & Short-Term Investments | 503.07 | 762.53 | 1,011 | 1,389 | 1,835 |
Cash Growth | -34.03% | -24.61% | -27.18% | -24.32% | -30.26% |
Accounts Receivable | - | - | - | 5.31 | - |
Other Receivables | 2.23 | 9.95 | 5.92 | 27.39 | 15.83 |
Receivables | 2.23 | 9.95 | 5.92 | 32.7 | 15.83 |
Inventory | 62 | 31.26 | 34.78 | 40.16 | 31.4 |
Other Current Assets | 3.01 | 4.93 | 15.34 | 23.43 | 12.72 |
Total Current Assets | 570.3 | 808.67 | 1,067 | 1,485 | 1,895 |
Property, Plant & Equipment | 210.53 | 273.88 | 341.13 | 393.22 | 365.68 |
Other Intangible Assets | 191.49 | 582.97 | 711.22 | 893.68 | 816.29 |
Other Long-Term Assets | 14.58 | 14.85 | 26.27 | 19.28 | 39.6 |
Total Assets | 986.9 | 1,680 | 2,146 | 2,791 | 3,117 |
Accounts Payable | 130.46 | 40.15 | 53.67 | 71.16 | 72.08 |
Accrued Expenses | - | 29.74 | 51.03 | 75.49 | 88.26 |
Short-Term Debt | - | - | - | 137.3 | - |
Current Portion of Long-Term Debt | 218.1 | 361.63 | 105 | 5 | 5 |
Current Portion of Leases | 8.22 | 14.63 | 16.01 | 10.6 | 15.19 |
Current Unearned Revenue | 32.66 | 16.81 | 31.42 | 1 | 1.44 |
Other Current Liabilities | 4.95 | 2.11 | 7.34 | 10.29 | 16.93 |
Total Current Liabilities | 394.39 | 465.05 | 264.47 | 310.84 | 198.9 |
Long-Term Debt | 18 | 19.5 | 157.5 | 92.5 | 95 |
Long-Term Leases | 18.24 | 26.65 | 40.29 | 33.73 | 31.85 |
Total Liabilities | 430.64 | 511.2 | 462.26 | 437.06 | 325.75 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Additional Paid-In Capital | - | 6,081 | 6,081 | 6,081 | 6,081 |
Retained Earnings | -6,111 | -5,556 | -4,965 | -4,197 | -3,351 |
Treasury Stock | - | -0 | -0 | -0 | -0 |
Comprehensive Income & Other | 6,667 | 643.91 | 568.36 | 470.84 | 61.37 |
Shareholders' Equity | 556.26 | 1,169 | 1,684 | 2,354 | 2,791 |
Total Liabilities & Equity | 986.9 | 1,680 | 2,146 | 2,791 | 3,117 |
Total Debt | 262.56 | 422.4 | 318.8 | 279.13 | 147.04 |
Net Cash (Debt) | 240.51 | 340.13 | 692.65 | 1,110 | 1,688 |
Net Cash Growth | -29.29% | -50.90% | -37.59% | -34.26% | -32.69% |
Net Cash Per Share | 0.58 | 0.82 | 1.68 | 2.71 | 4.22 |
Filing Date Shares Outstanding | 413.16 | 404.7 | 401.56 | 400.2 | 396.79 |
Total Common Shares Outstanding | 413.16 | 404.7 | 401.56 | 400.2 | 396.79 |
Working Capital | 175.91 | 343.62 | 803.02 | 1,174 | 1,696 |
Book Value Per Share | 1.35 | 2.89 | 4.19 | 5.88 | 7.03 |
Tangible Book Value | 364.77 | 586.2 | 972.62 | 1,461 | 1,975 |
Tangible Book Value Per Share | 0.88 | 1.45 | 2.42 | 3.65 | 4.98 |
Machinery | - | 217.95 | 216.21 | 189.32 | 147.47 |
Construction In Progress | - | 0.07 | 0.85 | 32.9 | 17.16 |
Leasehold Improvements | - | 234.33 | 234.76 | 234.66 | 208.38 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.